Skip to main content
. 2025 Nov 2;16(11):1312. doi: 10.3390/genes16111312
NSCLC Non-small-cell lung cancer
miR-200 microRNA-200 family
ZEB1/2 Zinc finger E-box-binding homeobox 1/2
EMT Epithelial–mesenchymal transition
EGFR Epidermal growth factor receptor
PD-L1 Programmed death-ligand 1
CD8+ T cell Cluster of differentiation 8-positive T lymphocyte
TKI Tyrosine kinase inhibitor
TGF-β Transforming growth factor beta
Wnt Wingless/INT signaling pathway
LEF Lymphoid enhancer-binding factor
HEY1/2 Hairy/enhancer-of-split related with YRPW motif 1/2
CpG Cytosine-phosphate-guanine dinucleotide
VEGFR1 Vascular endothelial growth factor receptor 1
FLT1 Fms-related tyrosine kinase 1
CXCL C-X-C motif chemokine ligand
CSC Cancer stem cell
CD133 Cluster of differentiation 133
ALDH1 Aldehyde dehydrogenase 1
PI3K Phosphoinositide 3-kinase
AKT Protein kinase B
LIN28B Lin-28 homolog B
3′-UTR 3′ untranslated region
TPS Tumor proportion score
PD-1 Programmed cell death protein 1
TIM-3 T cell immunoglobulin and mucin domain-containing protein 3
LAG-3 Lymphocyte activation gene 3
AUC Area under the curve
RT-PCR Reverse-transcription polymerase chain reaction
EV Extracellular vesicle
DNMT DNA methyltransferase
HDAC Histone deacetylase